Just like a marathon, you’ll start at the beginning, quickly cover lots of ground, have an incredible journey of learning AND be recognized for your accomplishment!
Your patients will appreciate that you chose to go the extra distance in being prepared to address their health questions related to the endocannabinoid system and the clinical aspects of medical marijuana.
Marij-thon: Comprehensive Medical Marijuana Course provides a total of 4.0 credit hours and includes the following three courses:
1. The Comprehensive Medical Marijuana Curriculum introduces the reader to the endocannabinoid system and its interaction with the components of the cannabis plant, and addresses administration, therapeutic use, drug metabolism, physiologic and cognitive effects, potential risks, and drug interactions.
The use of marijuana in obstetric patients, pediatric patients, adolescent patients and elderly patients is addressed in detail. Important considerations for patients with ischemic heart disease, hepatic disease, psychotic illness, and those with a history of drug dependence are provided.
2. Health Effects of Marijuana and Cannabinoids in Epilepsy describes how the endocannabinoid system may affect seizure threshold, and reviews the available research and clinical evidence for the use of marijuana or cannabinoids in the treatment of epilepsy. In addition, there is a discussion about an FDA-approved cannabis-based medicine for the treatment of Dravet syndrome and Lennox-Gastaut syndrome which are two rare and severe forms of epilepsy.
3. Legal and Medical Considerations in the Recommendation of Medical Marijuana provides a thorough review of the considerations associated with the recommendation of medical marijuana, and information on the prescribing of FDA-approved cannabinoid-based medicines.
Subscribers can complete this CME/CE activity and refer back to the content at any point during their 12-month subscription period.
Content provides Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE), American Association of Nurse Practitioners (AANP), American Nurses Credentialing Center (ANCC), and American Psychological Association (APA) credits.
I don’t plan on recommending marijuana…why would I take this course?
Whether or not you have any intention of recommending medical marijuana for patient care, you need to be well educated in this clinical area because your patients will be seeking your expert advice and guidance for this medication. Further, some of your patients may already be utilizing medical marijuana and you will need to be aware of its physiologic effects as well as its potential drug interactions. As such, expertise in the endocannabinoid system and medical marijuana is paramount for most doctors, pharmacists, nurses, psychologists, and other allied health professionals to remain that respected guide for their patients’ overall healthcare.
Table of Contents:
The Comprehensive Medical Marijuana Curriculum is comprised of 4 lessons:
- Lesson 1: The Endocannabinoid System and Phytocannabinoids
Lesson 1 introduces the reader to the endocannabinoid system and its interaction with the components of the cannabis plant. Lesson 1 also includes an explanation of the pharmacological properties of the major and minor phytocannabinoids.
- Lesson 2: Marijuana Products, Modes of Administration and Pharmacokinetics
Lesson 2 discusses a variety of marijuana products, various modes of administration and the pharmacokinetic properties of marijuana and cannabinoid-based products.
- Lesson 3: Precautions: The Use of Cannabinoid-based Drugs in Special Patient Populations and Cannabinoid-based Drug Metabolism and Potential Cannabinoid-based Drug Interactions
Lesson 3 addresses the use of marijuana in obstetric patients, pediatric patients, adolescent patients and elderly patients. Important considerations for patients with ischemic heart disease, hepatic disease, psychotic illness, and those with a history of drug dependence are provided, as well. Lesson 3 also discusses cannabinoid-based drug metabolism and potential cannabinoid-based drug interactions.
- Lesson 4: Physiologic and Cognitive Effects of Marijuana
Lesson 4 provides a detailed description of the physiologic and cognitive effects of marijuana.
The Health Effects of Marijuana and Cannabinoids in Epilepsy is comprised of 1 lesson:
- Lesson 1: The Health Effects of Marijuana and Cannabinoids in Epilepsy
Lesson 1 describes how the endocannabinoid system may affect seizure threshold, and reviews the available research and clinical evidence for the use of marijuana or cannabinoids in the treatment of epilepsy. In addition, there is a discussion about an FDA-approved cannabis-based medicine for the treatment of Dravet syndrome and Lennox-Gastaut syndrome which are two rare and severe forms of epilepsy.
Legal and Medical Considerations in the Recommendation of Medical Marijuana (Along with Information on the Prescribing of FDA-approved Cannabinoid-based Medicines) is comprised of 3 lessons:
- Lesson 1: The Laws, The Rules and The Regulations
Lesson 1 discusses the legal issues impacting the production, distribution and use of medical marijuana. Specifically, this lesson describes the statutes, judicial decisions, and administrative efforts which have shaped the federal posture and influenced the ability of individual states to enact medical marijuana programs.
- Lesson 2: Recommending Medical Marijuana
Lesson 2 begins with a discussion of the Federation of State Medical Boards’ “Model Guidelines for the Recommendation of Marijuana in Patient Care” and then transitions into a discussion about the medical literature on the health effects of marijuana use. Specifically, the National Academies of Science, Engineering and Medicine’s 2017 publication, The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research will be described in detail. Lesson 2 also addresses interpreting the results of studies that examine the effects of marijuana use.
- Lesson 3: The FDA Drug Approval Process and FDA-approved Cannabinoid-based Medicines
Lesson 3 reviews the United States Food and Drug Administration’s (FDA) drug approval process, and provides a description of cannabinoid-based medications that have been approved by the FDA.